The cluster is too small to drive a trading signal. Monitor for any upcoming earnings or pipeline catalysts that could explain the timing, but the dollar amounts suggest routine diversification. No action warranted.
ARQT drugs
ARQT drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 4 $23.49entry
- T+1 · 7mo ago −0.30%α −1.09% · $23.42
- T+5 · 6mo ago −9.58%α −12.51% · $21.24
- T+20 · 6mo ago −8.60%α −14.24% · $21.47
- T+60 · 4mo ago +18.60%α +16.75% · $27.86
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Four Arcutis insiders sold a total of $283K in open-market sales over a one-week window, including the CFO and three other executives. The cluster is modest in size (0.01% of market cap) and occurred near the stock's recent highs, suggesting routine portfolio diversification rather than a coordinated bearish signal. The cross-filing actuarial verdicts amplify the cluster's significance, but the absolute dollar value is too small to warrant a directional call.
Key Financial Metrics
Key Facts
- Four insiders sold a total of $283K in open-market sales from May 4-11, 2026
- CFO Latha Vairavan sold $32K; Matsuda Masaru sold $172K (largest trade)
- Total sales represent ~0.01% of ARQT's $2.6B market cap, well below the 0.1% materiality threshold
- All sales were open-market (code S); no non-cash transactions in the cluster
- Stock traded between $21.05 and $23.61 during the window, near recent highs
Financial Impact
$283K in insider sales, negligible relative to $2.6B market cap
Risk Factors
- Insider sales could accelerate if the stock continues to rally
- No material business catalyst identified, cluster may be purely liquidity-driven
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ARQT-1778715778269 |
Track record
34 reports on ARQT
3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +21.34% at T+60 after the Aug 5, 2026 report. 4 of 4 went positive at some point.
Filters
- Nov 13, 20263d ago Press Release Neutral 4/10 Entry $28.26 Now $27.15 −3.93% settles Feb 11
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $27.39 Now $27.15 −0.86% settles Feb 8
- Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Entry $25.55 Now $27.15 +6.26% settles Feb 4
- Nov 4, 202612d ago 3/A / CLUSTER / 3 Neutral 2/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
- Nov 4, 202612d ago 144 Neutral 3/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
- Nov 4, 202612d ago 424B5 Bearish 4/10 Entry $27.00 Now $27.15 −0.56% settles Feb 3
- Nov 4, 202612d ago 8-K Neutral 5/10 No price data
- Nov 4, 202612d ago Press Release Mixed 6/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $32.00 Now $27.15 −15.16% settles Feb 1
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $32.00 Now $27.15 −15.16% settles Feb 1
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers